Does Semaglutide Affect Muscle Mass — and What Can You Do About It?

What actually happens to muscle when you lose weight on semaglutide?

The honest starting point is that any treatment producing meaningful weight loss will reduce both fat mass and lean mass to some extent. That is a physiological reality of calorie restriction, not a specific failing of semaglutide. The question is the ratio.

In the STEP 1 trial, published in the New England Journal of Medicine, adults taking 2.4mg semaglutide over 68 weeks lost an average of around 15% of body weight. Body-composition sub-studies from the STEP programme found that roughly 20–30% of total mass lost was lean tissue, which sits within the range seen in other weight-loss interventions and is lower than the lean-mass proportion lost after bariatric surgery in some comparisons.

So semaglutide does reduce muscle mass alongside fat. It does not selectively strip muscle. The degree to which lean tissue is affected is substantially modifiable by what you do during treatment. If you want to go deeper on the composition data, our dedicated page exploring whether semaglutide reduces muscle mass covers the sub-study figures in more detail, alongside a breakdown of the fat-to-lean ratios seen across the STEP programme.

One point worth noting: body weight on the scales conflates fat, water, glycogen and lean tissue. Early in treatment, glycogen stores fall and water follows, that phase can look like dramatic loss but does not represent muscle depletion in the clinical sense.

Why the ratio of fat-to-muscle loss matters for your decision

The split between fat and muscle loss is not cosmetic. Muscle tissue drives resting metabolic rate, supports joint health, regulates blood glucose and protects against functional decline as we age. Losing a large proportion of lean mass alongside fat can slow the metabolism more than fat-only loss would, which makes long-term weight maintenance harder.

For most people starting semaglutide for weight management, the bigger metabolic risk before treatment is excess adiposity, not muscle loss, and significant fat reduction brings well-documented cardiovascular and metabolic benefits. The NHS describes these benefits on its semaglutide medicines page. The goal, clinically, is to lose fat and preserve as much muscle as possible rather than to avoid all lean-tissue change.

This is where the decision framing becomes practical. The people who preserve the most lean mass during semaglutide treatment in trial analyses tend to share certain behaviours: higher protein consumption, progressive resistance training and a more gradual rate of weight loss. None of those require special equipment or a gym membership. If you're already active, you're starting in a better position than you might think.

It's also worth knowing that body weight isn't the only marker that matters. Muscle function (strength, mobility, capacity) often improves when someone moves from a BMI above 35 to a healthier weight, even if the absolute lean tissue figure is slightly lower. The scales don't capture that.

Does Wegovy affect muscle mass differently from other semaglutide products?

Wegovy is the brand of semaglutide licensed specifically for weight management in the UK, the same active molecule, at a higher maintenance dose (up to 2.4mg weekly by injection, with a newer 7.2mg option now approved) than is used in diabetes treatment. When people ask whether Wegovy affects muscle mass, the answer follows the same evidence base: the STEP trials used Wegovy's dosing regimen, so the composition data above applies directly.

There is no head-to-head body-composition trial comparing Wegovy to tirzepatide (Mounjaro) specifically for lean mass preservation at the time of writing. SURMOUNT-5, published in 2025, showed tirzepatide produced greater average weight loss than semaglutide 2.4mg over 72 weeks, but greater total weight loss does not automatically mean worse muscle-mass outcomes; it depends on the fat-to-lean ratio, and direct composition comparisons between the two are ongoing.

If you are weighing up these options, our Wegovy overview covers the licensed indications and dosing schedule in full. Decisions about which medicine suits your health picture are made by a prescriber, not by comparing marketing claims.

What you can do to protect muscle during treatment

Three things have reasonable evidence behind them for preserving lean mass during a calorie deficit, and none require you to overhaul your life before a consultation:

Protein intake. Protein is the primary substrate for muscle repair and synthesis. Many people on semaglutide find appetite drops sharply, and if overall food volume falls dramatically, protein is often the casualty. Prioritising protein-dense foods (eggs, fish, legumes, Greek yoghurt, meat) before filling the rest of the plate tends to help. UK dietetic guidance generally points to 1.2–1.6g of protein per kilogram of body weight as a reasonable range during active weight loss, though personal targets should be discussed with your prescriber or a dietitian.

Resistance activity. Even two sessions a week of bodyweight or light resistance work (squats, rows, press-ups) sends a signal to preserve muscle tissue. Cardiovascular exercise supports health broadly but does less to protect lean mass specifically. You do not need a gym; you need load.

Rate of loss. Very rapid weight loss tends to produce a worse fat-to-muscle ratio. The titration schedule for semaglutide is designed partly to avoid a crash, gradual dose increases, gradual weight change. If you find weight is falling very fast, that is worth raising with your prescriber at the next review.

Treatment pricing context, if that's on your mind, is covered on our Wegovy cost page. Costs vary by dose and provider; what matters most here is that treatment is clinically reviewed at every stage, including monitoring your progress. If a consultation fits better after payday or on a Monday before the working week starts, the service runs seven days and the process takes minutes online.

If you are ready to explore whether semaglutide is suitable for you, including guidance from trainer James Smith on using semaglutide as part of a broader plan, a free consultation with our prescribers is the right place to start. A real clinician reviews every application the same day.